The Genetics Podcast
The Genetics Podcast
Sano Genetics
EP 266: How patient communities are accelerating rare disease research with Tania Simoncelli of Biohub
47 minutes Posted Nov 19, 2026 at 12:00 pm.
Intro to The Genetics Podcast00:59 Welcome to Tania01:41 The founding story and aim of the Rare As One Project05:17 Impact and scale of the Rare As One network, from funding to clinical trials10:45 Why cycle four focuses on rare respiratory, immune dysregulation and sarcoma communities14:54 How rare disease data and patient networks connect to Biohub’s virtual cell and AI models 19:00 The Rare As One partnership with Every Cure on AI-driven drug repurposing 24:29 Rare As One partnerships with the Broad Institute, Citizen Health and the Fowler lab28:49 Organizational and scientific capacity building for patient-led rare disease organizations34:03 Tania’s ACLU case against human gene patents and its impact 43:26 How patient communities are adopting AI and where it could take rare disease research46:33 Closing remarks
0:00
47:55
Download MP3
Show notes
This week on The Genetics Podcast, Patrick is joined by Tania Simoncelli, Vice President of Translational Impact and Engagement at Biohub. They discuss how patient-led organizations drive rare disease research, the capacity building and partnerships behind the Rare As One network, how AI could change drug repurposing and clinical trials, and Tania’s role in the ACLU case against human gene patents.Show Notes0:00 Intro to The Genetics Podcast00:59 Welcome to Tania01:41 The founding story and aim of the Rare As One Project05:17 Impact and scale of the Rare As One network, from funding to clinical trials10:45 Why cycle four focuses on rare respiratory, immune dysregulation and sarcoma communities14:54 How rare disease data and patient networks connect to Biohub’s virtual cell and AI models 19:00 The Rare As One partnership with Every Cure on AI-driven drug repurposing 24:29 Rare As One partnerships with the Broad Institute, Citizen Health and the Fowler lab28:49 Organizational and scientific capacity building for patient-led rare disease organizations34:03 Tania’s ACLU case against human gene patents and its impact 43:26 How patient communities are adopting AI and where it could take rare disease research46:33 Closing remarks